Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.5.2 and removal of v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:07:55.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:59.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T14:38:28.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The funding lapse notice and the previous Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T01:46:21.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A site-wide funding status notice was added and the record history now shows revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T22:53:41.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Show glossary option added and color-coded diffs (green for additions, red for deletions) on the history page. Revision note updated to v3.4.0 and older revision text removed along with the No FEAR Act data reference.
    Difference
    0.5%
    Check dated 2026-01-27T20:44:36.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.